Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer

Clinical trial NCT00704938 · TERMINATED

Trial details

NCT number: NCT00704938
Sponsor: National Institutes of Health Clinical Center (CC)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Cancer Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2008-06-01
Primary completion: 2009-08-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.